CIK 0001727196
- Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823750435
- Phone
- +1 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-20 | Nashat Amir Director | Other disposition | −276 | 0 | ||
| 2023-11-20 | Nashat Amir Director | Other acquisition | +37 | 20,574 | ||
| 2023-11-02 | Myles Edward H COO & CFO | Sale 10b5-1 | −35,007 | $12.51 | $438K | 168,784 |
| 2023-10-16 | AKKARAJU SRINIVAS Director | Purchase | +2,189,781 | $6.85 | $15.0M | 6,788,609 |
| 2023-10-16 | Samsara BioCapital GP, LLC 10% owner | Purchase | +2,189,781 | $6.85 | $15.0M | 6,788,609 |
| 2023-10-12 | Invus Public Equities, L.P. 10% owner | Purchase | +2,189,781 | $6.85 | $15.0M | 11,249,288 |
| 2023-10-12 | Invus Public Equities, L.P. 10% owner | Purchase | +10,150 | $8.55 | $87K | 11,259,438 |
| 2023-09-18 | Qatanani Mo SVP AND HEAD OF RESEARCH | Sale | −1,945 | $6.34 | $12K | 97,043 |
| 2023-08-16 | Parlavecchio Caryn CHRO | Sale | −1,353 | $6.83 | $9K | 117,199 |
| 2023-06-21 | Burow Kristina Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-06-21 | Nashat Amir Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-06-21 | Vaishnaw Akshay Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-06-21 | Reed Joshua Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-06-21 | Gilman Michael Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-06-21 | FLIER JEFFREY S. Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-06-21 | AKKARAJU SRINIVAS Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-06-21 | Hallal David Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2023-06-21 | Parlavecchio Caryn CHRO | Shares withheld for taxes | −4,038 | $8.75 | $35K | 118,552 |
| 2023-06-21 | Myles Edward H COO & CFO | Shares withheld for taxes | −7,138 | $8.75 | $62K | 203,791 |
| 2023-06-21 | Ho Junlin GENERAL COUNSEL | Shares withheld for taxes | −4,346 | $8.75 | $38K | 158,591 |
Page 19 of 22 · 422 trades